David Kropaczek, director of the Consortium for Advanced Simulation of Light Water Reactors, or CASL, at the Department of Energy’s Oak Ridge National Laboratory, has been named a fellow of the American Nuclear Society.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.